These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32216180)

  • 1. [Physical activity : under-used therapeutic option in the treatment of metabolic diseases].
    Pralong F; Gojanovic B
    Rev Med Suisse; 2020 Mar; 16(687):578-581. PubMed ID: 32216180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physical exercise and its prescription in patients with chronic degenerative diseases].
    Gómez R; Monteiro H; Cossio-Bolaños MA; Fama-Cortez D; Zanesco A
    Rev Peru Med Exp Salud Publica; 2010 Sep; 27(3):379-86. PubMed ID: 21152731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Algorithms based on medico-administrative data in the field of endocrine, nutritional and metabolic diseases, especially diabetes].
    Fosse-Edorh S; Rigou A; Morin S; Fezeu L; Mandereau-Bruno L; Fagot-Campagna A
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S168-S173. PubMed ID: 28625707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FITT principle of exercise in the management of lifestyle-related diseases].
    Katsukawa F
    Clin Calcium; 2016 Mar; 26(3):447-51. PubMed ID: 26923984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of exercise-induced hepatokines in metabolic disorders.
    Ennequin G; Sirvent P; Whitham M
    Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.
    McIntyre RS; Alsuwaidan M; Goldstein BI; Taylor VH; Schaffer A; Beaulieu S; Kemp DE;
    Ann Clin Psychiatry; 2012 Feb; 24(1):69-81. PubMed ID: 22303523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DYSLIPIDEMIA IN MEXICO, A CALL FOR ACTION.
    Rivas-Gomez B; Almeda-Valdés P; Tussié-Luna MT; Aguilar-Salinas CA
    Rev Invest Clin; 2018; 70(5):211-216. PubMed ID: 30307444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing of Electronic Activity Monitors in Cardiometabolic Diseases: Qualitative Interview-Based Study.
    Bellicha A; Macé S; Oppert JM
    J Med Internet Res; 2017 Sep; 19(9):e328. PubMed ID: 28947415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
    Monteleone P; Martiadis V; Maj M
    Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upright water-based exercise to improve cardiovascular and metabolic health: a qualitative review.
    Meredith-Jones K; Waters D; Legge M; Jones L
    Complement Ther Med; 2011 Apr; 19(2):93-103. PubMed ID: 21549260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia in the metabolic syndrome in children.
    Gidding SS
    J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for prescribing exercise as therapy in chronic disease.
    Pedersen BK; Saltin B
    Scand J Med Sci Sports; 2006 Feb; 16 Suppl 1():3-63. PubMed ID: 16451303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidence.
    Stone NJ
    Am J Cardiol; 2008 Dec; 102(12A):14L-18L. PubMed ID: 19084085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors.
    Buffier P; Bouillet B; Smati S; Archambeaud F; Cariou B; Verges B
    Ann Endocrinol (Paris); 2018 Oct; 79(5):574-582. PubMed ID: 30174137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database.
    Brixner D; Ghate SR; McAdam-Marx C; Ben-Joseph R; Said Q
    J Manag Care Pharm; 2008 Oct; 14(8):756-67. PubMed ID: 18983205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.